1. Translation and validation of PREM-questionnaire. (February 2017) Authors: Tolstrup, L.; Dieperink, K.; Pappot, H.; Zwisler, A.D.; Bastholt, L. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S139 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. EURO-VOYAGE: Effectiveness and safety of ipilimumab (IPI) administered during a European Expanded Access Programme (EAP) in patients with advanced melanoma (MEL). (February 2017) Authors: Ascierto, P.; Bastholt, L.; Mohr, P.; Hoeller, C.; Robert, C.; Larkin, J.; Dummer, R.; Ekbom, A.; Chiarion-Sileni, V.; Dutriaux, C.; Mortier, L.; Neyns, B.; Nyakas, M.; Garbe, C.; Baurain, J.F.; Kruse, V.; Svane, I.M.; Alfaya, L.; Ciria, C.; Blank, C. Journal: European journal of cancer Issue: Volume 72(2017)Supplement 1 Page Start: S128 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. More than 5000 patients with metastatic melanoma in Europe per year do not have access to recommended first-line innovative treatments. (April 2017) Authors: Kandolf Sekulovic, L.; Peris, K.; Hauschild, A.; Stratigos, A.; Grob, J.-J.; Nathan, P.; Dummer, R.; Forsea, A.-M.; Hoeller, C.; Gogas, H.; Demidov, L.; Lebbe, C.; Blank, C.; Olah, J.; Bastholt, L.; Herceg, D.; Neyns, B.; Vieira, R.; Hansson, J.; Rutkowski, P. Journal: European journal of cancer Issue: Volume 75(2017) Page Start: 313 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Which medical disciplines diagnose and treat melanoma in Europe in 2019? A survey of experts from melanoma centres in 27 European countries. (10th February 2021) Authors: Kandolf‐Sekulovic, L.; Peris, K.; Stratigos, A.; Hauschild, A.; Forsea, A.‐M.; Lebbe, C.; Lallas, A.; Grob, J.‐J.; Harwood, C.; Gogas, H.; Rutkowski, P.; Olah, J.; Kelleners‐Smeets, N.W.J.; Paoli, J.; Dummer, R.; Moreno‐Ramirez, D.; Bastholt, L.; Putnik, K.; Karls, R.; Hoeller, C. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 35:Number 5(2021) Page Start: 1119 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Access to innovative medicines for metastatic melanoma worldwide: Melanoma World Society and European Association of Dermato-oncology survey in 34 countries. (November 2018) Authors: Kandolf Sekulovic, L.; Guo, J.; Agarwala, S.; Hauschild, A.; McArthur, G.; Cinat, G.; Wainstein, A.; Caglevic, C.; Lorigan, P.; Gogas, H.; Alvarez, M.; Duncombe, R.; Lebbe, C.; Peris, K.; Rutkowski, P.; Stratigos, A.; Forsea, A.-M.; De La Cruz Merino, L.; Kukushkina, M.; Dummer, R. Journal: European journal of cancer Issue: Volume 104(2018) Page Start: 201 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. PD‐L1 expression and survival among melanoma patients treated with standard immunotherapy or chemotherapy. (31st January 2017) Authors: Steiniche, T.; Vestergaard Danielsen, A.; Wang, Z.; Feng, Y.; Switten Nielsen, P.; Bastholt, L.; Schmidt, H.; Svane, I.M.; Dolled‐Filhart, M.; Emancipator, K.; Weiner, R.; Busch‐Sørensen, M.; Zhou, W. Journal: Journal of the European Academy of Dermatology and Venereology Issue: Volume 31:Number 7(2017) Page Start: e319 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗